Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells
Abstract
Because metformin affects glucose and free fatty acid (FFA) metabolism in peripheral insulin target tissues, we investigated the effect of this drug in restoring a normal secretory pattern in rat pancreatic islets whose function has been impaired by chronic exposure to elevated FFA or glucose concentrations. We cultured rat pancreatic islets with or without FFA (2 mmol/l oleate/palmitate 2:1) or high glucose (16.7 mmol/l) concentrations in the presence or absence of metformin (0.25-12.5 microg/ml) and then measured insulin release, glucose utilization, glucose, and FFA oxidation. When compared with control islets, islets exposed to high FFA or glucose concentrations showed an increased basal and a decreased glucose-induced insulin release. In islets cultured for an additional 24 h with FFA or glucose in the presence of metformin (2.5 microg/ml), both basal and glucose-induced insulin secretions were restored. Both glucose utilization and glucose oxidation were altered in islets pre-exposed to high FFA or glucose concentrations. In particular, regarding control islets, glucose utilization was increased at 2.8 mmol/l glucose and decreased at 16.7 mmol/l glucose; glucose oxidation was similar to control islets at 2.8 mmol/l glucose but decreased at 16.7 mmol/l glucose. In contrast, oleate oxidation was increased in islets pre-exposed to FFA. All of these abnormalities were reversed in islets cultured for an additional 24 h with high FFA or glucose concentrations in the presence of metformin (2.5 microg/ml). In conclusion, our data show that metformin is able to restore the intracellular abnormalities of glucose and FFA metabolism and to restore a normal secretory pattern in rat pancreatic islets whose secretory function has been impaired by chronic exposure to elevated FFA or glucose levels. These data raise the possibility that, in diabetic patients, metformin (in addition to its peripheral effects) may have a direct beneficial effect on the beta-cell secretory function.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Metformin's metabolic actions include reducing intestinal glucose absorption, restoring insulin secretion in pancreatic beta-cells, and increasing insulin-mediated glucose uptake in muscle and adipose.
“metformin’s metabolic action includes a reduction in glucose absorption in the intestine (Wu et al. 2017), restoring insulin secretion in pancreatic beta-cells (Patane et al. 2000) and to a lesser extent increasing insulin-mediated glucose uptake in the peripheral tissues of muscle and adipose (Galuska et al. 1991).”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Patane et al. 2000
The citation lists haven’t been fetched yet
References 30 · Cited by 169
- Authors
- Patanè, G., Piro, S., Rabuazzo, A. M., Anello, M., Vigneri, R., & Purrello, F.
- Affiliations
- University of Catania (IT)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2000-05-01
- Volume
- 49
- Issue
- 5
- Pages
- 735-740
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2111497885
- Cited by
- 169
- References
- 30
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 1 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 9 · 2018: 11 · 2017: 6 · 2016: 8 · 2015: 4 · 2014: 9 · 2013: 9 · 2012: 6
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, insulin secretion, pancreatic beta cells, pancreatic islets, free fatty acids, high glucose, glucose metabolism, fatty acid oxidation, glucose utilization, type 2 diabetes, beta-cell dysfunction
- MeSH terms
- Insulin Secretion, Animals, Dose-Response Relationship, Drug, Fatty Acids, Nonesterified, Glucose, Hypoglycemic Agents, Insulin, Islets of Langerhans, Male, Metformin, Oxidation-Reduction, Time Factors, Triglycerides, Rats, Wistar, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review